American Journal of Psychiatry

Article	Citations
Broadening the Parameters of Clinical High Risk for Psychosis	465
2024 Annual Meeting: Presidential Address	197
A New Agenda for Optimizing Investments in Community Mental Health and Reducing Disparities	135
Evaluating Associations Between Cannabis and Heroin Use	128
Treating Pathologies of the Will	126
Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia	122
Mental Health Disparities Research: An Introduction to New Directions	112
Highlights From the Residents’ Journal: December 2021	109
A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now	108
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies?	105
Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders	96
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?	94
Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology	93
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial	89
Depression, Inflammation, and Postpartum Psychosis	89
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?	89
From Prediction to Action: Moving Beyond Machine Learning to Implementing Evidence-Based Perinatal Mental Health Care	86
Intentional Drug Overdose Deaths in the United States	86
Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma	83
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosi	83
On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide	82
From Scanner to Bedside: Building Bridges in Translational Psychiatric Neuroimaging	80
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis	80
New Insights Into Psychotic Disorders	80
Trends in Prescription Stimulant, Opioid, and Benzodiazepine Use and Diversion in U.S. Adolescents	77

12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use	73
2024 Annual Meeting: CEO and Medical Director’s Address	71
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression	71
Highlights From the Residents’ Journal: September 2021	67
Correcting Overestimations in Self-Harm Visit Data	66
Highlights From the Residents’ Journal: September 2024	65
APA Council Reports	65
Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek	62
Correction to Poirot et al.	59
Corrigendum to Morley et al.	59
Neural Responses to Intranasal Oxytocin in Youths With Severe Irritability	58
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.	57
Suicide and the Menstrual Cycle	57
Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder	55
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression	54
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression	53
Familial Risk of Postpartum Psychosis	53
Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population	53
Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia	52
The First Large GWAS Meta-Analysis for Postpartum Depression	51
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden	51
Whole Brain White Matter Tract Deviation and Idiosyncrasy From Normative Development in Autism and ADHD and Unaffected Siblings Link With Dimensions of Psychopathology and Cognition	50
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials	50
Coordinate Network Mapping: An Emerging Approach for Morphometric Meta-Analysis	50
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial	49
Genetic and Environmental Contribution to the Co-Occurrence of Endocrine-Metabolic Disorders and Depression: A Nationwide Swedish Study of Siblings	48
Early Adversity and Development: Parsing Heterogeneity and Identifying Pathways of Risk and Resilience	48
Sexual Identity Continuity and Change in a U.S. National Probability Sample of Sexual Minority Adults: Associations With Mental Health and Problematic Substance Use	46
Associations Between a Primary Care-Delivered Alcohol-Related Brief Intervention and Subsequent Opioid-Related Outcomes	45
Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh	44
Rebecca W. Brendel, M.D., J.D., 149th President, 2022–2023	42
Proof-of-Principle Study on ECT Illustrates Challenges and Possible Merits of Using Polygenic Risk Scores to Predict Treatment Response in Psychiatry	42
Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities	42
Alcohol and the Etiology of Depression	41
The Neglected Role of Psychotherapy for Treatment-Resistant Depression	41
The Safety of Pimavanserin for Parkinson’s Disease and Efforts to Reduce Antipsychotics for People With Dementia	41
Comment on “Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank”	41
Predictive Value of Acute Neuroplastic Response to rTMS in Treatment Outcome in Depression: A Concurrent TMS-fMRI Trial	40
Shared and Specific Neural Correlates of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: A Meta-Analysis of 243 Task-Based Functional MRI Studies	39
Aberrant Developmental Patterns of Gamma-Band Response and Long-Range Communication Disruption in Youths With 22q11.2 Deletion Syndrome	39
Suicide in Black Females	38
Risk of Incident Psychosis and Mania With Prescription Amphetamines	38
2021 Articles of Import and Impact	38
Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment	38
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression	37
Slowly Working Toward More Treatments for Depression in Bipolar II Disorder	37
Cigarette Smoking and Heavy Alcohol Drinking: The Challenges and Opportunities for Combination Treatments	37
Reduction in Trauma-Related Symptoms After Anesthetic-Induced Intra-Operative Dreaming	37
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary	36
Synaptic Variability and Cortical Gamma Oscillation Power in Schizophrenia	35

Psilocybin: From Psychiatric Pariah to Perceived Panacea	34
What Do Four Decades of Research Tell Us About the Association Between Childhood Adversity and Psychosis: An Updated and Extended Multi-Level Meta-Analysis	34
Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain	33
Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD	33
Neuromodulation Strategies for the Treatment of Depression	33
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder	33
Evaluating the Machine Learning Literature: A Primer and User’s Guide for Psychiatrists	32
Predicting Acute Changes in Suicidal Ideation and Planning: A Longitudinal Study of Symptom Mediators and the Role of the Menstrual Cycle in Female Psychiatric Outpatients With Suicidality	32
Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial	31
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders	31
Neural Correlates of Stress and Alcohol Cue-Induced Alcohol Craving and of Future Heavy Drinking: Evidence of Sex Differences	31
Can Smartphone-Based Support Apps Add Value to the Treatment of Opioid Use Disorder?	30
Interindividual Differences in Cortical Thickness and Their Genomic Underpinnings in Autism Spectrum Disorder	30
Mortality Among Parkinson’s Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries	30
Evaluating the Evidence for Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma	30
Correction to Baum et al.	30
The Association of Childhood Maltreatment and Mental Health Problems: Partly Causal and Partly Due to Other Factors	30
A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability	30
Toward Precision Noninvasive Brain Stimulation	30
A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial	29
Innovative Directions to Advance Mental Health Disparities Research	28
Drug Cues Trigger Corticolimbic Hyperreactivity in Heroin Users	28
Keeping Track and Providing Tools for Future Crisis Management: Suicide Attempt and Self-Harm Presentations at Emergency Departments	28
Beneath the Phenotypic Surface: Pleiotropy Shapes the Co-Occurrence of Alcohol Use Disorder and Psychopathology	27
Harnessing the Power of Population Cohorts to Study the Relationship Between Endocrine-Metabolic Disorders and Depression	27
Racial and Ethnic Biases and Psychiatric Misdiagnoses: Toward More Equitable Diagnosis and Treatment	27
When Will There Be Good News?	27
Setting the Record Straight on Long-Term Use, Dose Escalation, and Potential Misuse of Prescription Benzodiazepines	27
The Amygdala and Depression: A Sober Reconsideration	27
Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD	27
Differences in Social Determinants of Health Underlie Racial/Ethnic Disparities in Psychological Health and Well-Being: Study of 11,143 Older Adults	27
Psychiatric Diagnoses in Parents and Psychiatric, Behavioral, and Psychosocial Outcomes in Their Offspring: A Swedish Population-Based Register Study	26
Auditory Steady-State Responses Probe GABA-Related Oscillatory Cortical Circuits and Their Relation to Neurodevelopmental Mental Disorders	26
Correction	26
Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary	26
Understanding the Effects of Combined Lisdexamfetamine and Cognitive Behavior Therapy for Adults With Binge Eating Disorder	25
Guilt by Association: Inflammation and Shared Genetic Risk Between Stress-Related and Immune Disorders	25
Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?	25
2024 Articles of Import and Impact	25
Highlights From the Residents’ Journal: December 2024	25
Ketamine After Two Antidepressants?	25
Recommendations for the Usage of Ketamine and Esketamine	24
Progress and Challenges in GxE Research on Depression	24
Drugs and Addiction Science: NIDA Celebrates 50 Years of Research and Looks to the Future	23
Converging Evidence for Frontopolar Cortex as a Target for Neuromodulation in Addiction Treatment	23
Associations Between General and Specific Mental Health Conditions in Young Adulthood and Cardiometabolic Complications in Middle Adulthood: A 40-Year Longitudinal Familial Coaggregation Study of 672,	23
Longitudinal Trajectory of the Link Between Ventral Striatum and Depression in Adolescence	23
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial	23
Current and Future Approaches to Pediatric Anxiety Disorder Treatment	22
Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg	22
Technology and Mental Health: State of the Art for Assessment and Treatment	22
Time Course of Relapse Following Acute Treatment for Anorexia Nervosa	22
Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy	21
Functional Connectivity Mapping for rTMS Target Selection in Depression	21
Reports to the Membership	21
Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression	21
Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features	21
Cannabis Use and the Endocannabinoid System: A Clinical Perspective	21
Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?	21
Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia	20
Vaccines as Immunotherapies for Substance Use Disorders	20
Antidepressants and Bipolar Disorder: The Plot Thickens	20
Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population	20
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research	20
Perinatal Mental Health: Advances and Opportunities	20
Recapitulation of Perturbed Striatal Gene Expression Dynamics of Donors’ Brains With Ventral Forebrain Organoids Derived From the Same Individuals With Schizophrenia	20
Can Two 90-Minute Workshops Reduce Risk of Substance Use Disorder for Vulnerable Seventh Graders? Results and Scalability From the Co-Venture Trial	20
Psychotropic Drug–Related Weight Gain and Its Treatment	19
Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction	19
Late-Life Depression, Antidepressant Treatment, and Cognition: The Short Haul and the Long Haul	19
Polygenic Risk Scores and Genetics in Psychiatry	19
Behavior as Physiology: How Dynamical-Systems Theory Could Advance Psychiatry	19
An Insula-Enriched Regulator of Retinoic Acid Marks a New Intersection in the Neural Circuitry of Mouse Social Behavior	18
Pathogenic Variants and Ascertainment: Neuropsychiatric Disease Risk in a Health System Cohort	18
Putting Genetics to Work in the Psychiatric Clinic	18
Neglect of Adverse Effects in Treatment Guidelines for Depression	18
Highlights From the Residents’ Journal: September 2023	18
Intermittent Theta Burst Stimulation With Adjunctive D-Cycloserine for Obsessive-Compulsive Disorder: A Randomized Clinical Trial	17
Understanding the Value and Limitations of MRI Neuroimaging in Psychiatry	17
Varenicline as a First-Line Treatment for Individuals With Current Major Depressive Disorder Who Smoke Cigarettes	17

Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA Study	17
Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data	17
Focusing on Substance Use Disorders, Opioids, and Craving	17
Neuropsychiatric Symptoms of Subacute and Chronic Long COVID	17
Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment	17
Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder	16
Don’t Throw the Baby Out With the Bathwater: A Need for Nuanced Practice and Additional Research on Telehealth Management of ADHD	16
Increased Inflammation in Depression: A Little in All, or a Lot in a Few?	16
Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia	16
Reports to the Membership	16
The Devastating Clinical Consequences of Child Abuse and Neglect: Increased Disease Vulnerability and Poor Treatment Response in Mood Disorders	16
Clozapine’s High Incidence of Ileus and Pneumonia Demand Better Clinical Strategies—How Do We Get There?	16
Improved Response Inhibition Through Cognition-Guided EEG Neurofeedback in Men With Methamphetamine Use Disorder	16
New Insights Into Major Depression and the Treatment of Bipolar Depression	15
Highlights From the Residents’ Journal: June 2025	15
Intergenerational Effects of the Fast Track Intervention on Next-Generation Child Outcomes: A Preregistered Randomized Clinical Trial	15
Affective Disorders, Pharmacogenomics, and Psychiatric Illness-Related Cardiometabolic Problems	15
Disclosure of Editors’ Financial Relationships	15
Beyond the Landmarks: Where to Next With Biomarkers of Autism?	15
MORE Is Less Pain and Less Opioid Misuse: A Mindful Remedy	15
An Honest Reckoning With the Amygdala and Mental Illness	15
Psychosis Risk With Prescription Amphetamine	15
Treating Depression With Repetitive Transcranial Magnetic Stimulation: A Clinician’s Guide	14
The Intergenerational Impact of Structural Racism and Cumulative Trauma on Depression	14
What is the Link Between Substance-Induced Psychosis and Primary Psychotic Disorders?	14
Can Cognitive-Behavioral Therapy Normalize Neural Function in Youths With Pediatric Anxiety Disorders? A Developmental Neuroscience Perspective	14
Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark	14
MDMA and MDMA-Assisted Therapy	14
Disclosure of Editors’ Financial Relationships	14
Drug Overdose Prevention: An Exercise in Optimism	14
Clozapine, Long-Acting Injectables (and Polypharmacy?) Superior in U.S. and International Registries	14
Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All?	14
Association Between Polygenic Risk Scores and Outcome of ECT	14
Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression	14
Prospective Associations Between Structural Brain Development and Onset of Depressive Disorder During Adolescence and Emerging Adulthood	14
Prevalence of Suicidal Ideation and Suicide Attempts by Race and Gender in Three Large U.S. Adolescent Cohorts	13
20 Years of Aberrant Salience in Psychosis: What Have We Learned?	13
Mechanism-Focused Randomized Controlled Trials in Youths: Another Step Uphill	13
Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders	13
Inequalities in the Incidence of Psychotic Disorders Among Racial and Ethnic Groups	13
Grip Strength as a Marker of Resting-State Network Integrity and Well-Being in Early Psychosis	13
The Importance and Limitations of Null Findings	12
Adolescent Substance Use and Suicidal Behavior, Internet Overuse, and Shared Genetics Between Problematic Alcohol Use and Other Psychiatric Comorbidities	12
Psychopathology in Youth: Treatment, Parenting, and Intergenerational Transmission	12
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial	12
The Conundrum of Treatment Discontinuation of Stimulant Medication for ADHD Despite Its Efficacy	12
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis	12
Contraception, Intrauterine Systems, and Depression: Can We Spot the Real Perpetrator?	11
Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes	11
The Psychiatric Bed Crisis in the United States: Understanding the Problem and Moving Toward Solutions	11
Clarifying Confounder Variables and Cross-Sectional Power to Make Causal Conclusions About Race, Adversity, and Brain Differences: Response to Scheeringa	11
Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group	11
Science Into Policy for the Benefit of Children: The Bucharest Early Intervention Project	11
Correction to Lebois et al.	11
2021 Annual Meeting: President-Elect Address	11
Understanding and Addressing Widening Racial Inequalities in Drug Overdose	11
Ketamine, the First Associative Anesthetic? Some Considerations on Classifying Psychedelics, Entactogens, and Dissociatives	10
Psychotherapy’s Role for Treatment-Resistant Depression: Reply to Bartova et al.	10
Neuroscientific Advances Supporting New Treatments for Major Depression	10
Perspectives From the National Institutes of Health on Multidimensional Mental Health Disparities Research: A Framework for Advancing the Field	10
Predicting Conversion to Psychosis Using Machine Learning: Are We There Yet?	10
Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial	9
Correction to Mattes	9
In Search of Biomarkers to Guide Interventions in Autism Spectrum Disorder: A Systematic Review	9
Using Principles of Trauma-Informed Care to Address Structural Racism in Psychiatric Care	9
Suicide in Black Females: Response to Mattes	9
Cell Type–Specific Profiles and Developmental Trajectories of Transcriptomes in Primate Prefrontal Layer 3 Pyramidal Neurons: Implications for Schizophrenia	9
Cerebrovascular Disease and Neuropsychiatric Disorders: Translating Findings From the MRI Scanner to the Clinic	9
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic	9
Correction to Guintivano et al.	9
Sex-Differential Neuroanatomy in Autism: A Shift Toward Male-Characteristic Brain Structure	9
Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia	8
Infant Visual Brain Development and Inherited Genetic Liability in Autism	8
Psychiatric Genetics and Assessing Telehealth Prescribing of Controlled Substances	8
Genetic Underpinnings of the Transition From Alcohol Consumption to Alcohol Use Disorder: Shared and Unique Genetic Architectures in a Cross-Ancestry Sample	8
Reducing Duration of Untreated Psychosis: The Neglected Dimension of Early Intervention Services	8
Translational Neuroscience Approaches to Understanding Autism	8
Telemental Health Care for Children and Adolescents in the United States: Challenges and Opportunities	8
The Genetic Architecture of Obsessive-Compulsive Disorder: Contribution of Liability to OCD From Alleles Across the Frequency Spectrum	8
Charting the Landscape of Genetic Overlap Between Mental Disorders and Related Traits Beyond Genetic Correlation	8
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III)	8
ADHD and ASD: Time to Split or Lump?	8
Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects	8
Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019	8
Correcting Overestimations in Self-Harm Visit Data: Response From Bommersbach and Colleagues	8
Entactogen Effects of Ketamine: A Reverse-Translational Study	8
High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study	8
Polygenic Risk and Social Support in Predicting Depression Under Stress	8
More Than Social Stigma Meets the Eye: The Inherent Struggle of Sexual and Gender Identity Development Across the Lifespan	8
Structural Racism and the Imperative to Eliminate Mental Health Disparities	8
Racial and Ethnic Bias in the Diagnosis of Alcohol Use Disorder in Veterans	8
Lack of Representation in Psychiatric Research: A Data-Driven Example From Scientific Articles Published in 2019 and 2020 in the American Journal of Psychiatry	8
Association of Cannabis Use–Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001–2002 and 2012–2013	8
Through a Developmental Lens: Emerging Insights to Understand and Treat Pediatric PTSD	7
Peer Social Genetic Effects and the Etiology of Substance Use Disorders, Major Depression, and Anxiety Disorder in a Swedish National Sample	7